Supplements for Antiphospholipid Syndrome

What the Research Shows

Current clinical research on supplements for Antiphospholipid Syndrome (APS) is limited, with few large-scale studies available to establish definitive efficacy. There is moderate evidence regarding the role of Vitamin K, though its application is complex due to its relationship with blood-thinning medications. Most research focuses on managing the coagulation cascade rather than treating the underlying autoimmune process. For most other supplements, evidence remains weak or insufficient. While some small-scale studies explore antioxidants or omega-3 fatty acids to reduce inflammation, these have not been proven to prevent thrombotic events or pregnancy complications in APS patients. Many findings are based on animal models or small cohorts, meaning the results cannot be broadly applied to the general population. Overall, there is a significant lack of high-quality, randomized controlled trials to support the routine use of supplements for this condition.

AI-generated overview based on research evidence. Not medical advice.

This page is generated from AI-analyzed evidence summaries. Evidence strength ratings are based on the quality and quantity of available research, not guaranteed effectiveness. Always consult a healthcare provider before using supplements for any health condition.

See our Editorial Policy for methodology and Medical Disclaimer.